//DNA sequence being used
ATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCGGTTATGGTGTTCAATGCTTTGCGAGATACCCAGATCATATGAAACAGCATGACTTTTTCAAGAGTGCCATGCCTGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACTCACACAATGTATACATCATGGCAGACAAACAAAAGAATGGAATCAAAGTTAACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAA

// AA sequence being used
MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFGYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK

//Questions:
1. How to calculate fragment size? (can fragments be uneven in length)

2. %'s (is (targets in fragment/targets in whole seq) the correct equation or are we 
   comparing target aa's in fragment to total aa's in sequence)?

3. Got following %'s using example talked about and testing with sequence above:

    E [(0, 1), (3, 5)]{⟨0, 1, 2⟩, ⟨0, 3⟩} Delta = 15%
    
  31.25% in section [0,1], 0% in section [2], 43.75% in section [3..5],
  25.0% in section [6..9] (notes say to consider this as 10%)

  Design would produce 10%, 25%, 40%, 55%, 70%, 85% (matches initial inputs)

  - Why is last section considered 10% even though it contains 25%? (Do we manually reduce it to 10%?)
  - Design is always split into 4 sections with 2 sections having frequencies varied?

4. Modifying %'s
  - How to reduce percent to 0 delta when there are targets is overlap
  - % rounding buffer
    - go as close to % without exceeding
    - minimize % difference from target %
  - How to increase % if % is less than target even after replacing all variants with target aa?
    - Replace non variant with target aa?

5. Unique Overlap's
    - Do all overlaps in an oligo or cooresponding overlaps between oligo's have to be unique?

6. Can I assume the following inputs are given?
    - DNA Seq
    - Target Amino Acid (Codon)
    - Design (deltas and fragments) in following format [(0, 1), (3, 5)] {⟨0, 1, 2⟩, ⟨0, 3⟩}
    - # of Fragments 
    - Fragment Size (in aas)
    - Overlap Size (in aas)
    - Delta

7. Is correct output going to be x dna sequences where x is number of possible
   frequency combinations from design?